Global Vaccine Market predicted to be US$ 70 Billion by 2024 
27 Aug, 2018

Get Free Customization in This Report

According to Renub Research latest report on Vaccine industry Global Vaccine Market around the world would be US$ 70 Billion by the year 2024. Vaccine is considered as one of the best quality science across all streams pertinent in the field of Vaccinology. Vaccines are derived from the killed or inactivated pathogens, which are unable to cause any sickness to vaccinated people. When a person is vaccinated, it is impracticable for them to become sick with that particular disease. Early vaccination and the completion of complete vaccination schedule among the infants to their adulthood, helps reduce the prevalence of vaccine preventable diseases and its burden across the countries around the world.

Request a free sample copy of the report: https://www.renub.com/contactus.php

Vaccination is one of the best ways to protect infants, teens and elderly from almost 16 potentially harmful diseases which can be very fatal and may require hospitalization or even be deadly. Many people think that immunizations are just for infants while childhood vaccinations can wear off over a period of time and hence, adults may also be at serious risk of developing vaccine preventable diseases due to change in lifestyle, age and health conditions. 

Today, vaccination has helped to reduce the global burden of a range of viral and bacterial diseases around the world. Vaccination against the particular disease not only limits the incidence of that disease, but it also minimizes the socioeconomic burden of that disease in the society. An appropriate rate of immunization can lead to the substantial blocking of transmission for several vaccine preventable diseases. Today, the world has witnessed the eradication of smallpox and is near to the elimination of polio from most countries across the world due to the role of immunization in controlling disease.

List of some of the vaccine Preventable diseases include:

•    Diphtheria
•    Pertussis (whooping cough)
•    MMR (Measles, Mumps and Rubella)
•    Polio (poliomyelitis)
•    Haemophilus Influenzae type b infections (Hib)
•    Influenza
•    Hepatitis
•    Pneumococcal infections
•    Meningococcal disease
•    Varicella-zoster (chickenpox)
•    Human papillomavirus  (Cervical Cancer)
•    Tetanus
•    Yellow fever
•    Japanese encephalitis

How do Vaccines Work?

Vaccines work is to prime one’s immune system against future attacks by a specific disease. There are vaccines that work against both bacterial and viral pathogens and disease causing agents. When a pathogen enters in the immunized person’s body, the person’s immune system generates antibodies to fight it off. Depending upon the strength of one’s immune response and how effectively the antibodies scrap off the pathogen, one may or may not get ill.

Client can Purchase this Report in Sections from below link: 

Access full Research:

https://www.renub.com/global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php

When a person is vaccinated with whatever the version of a pathogen that vaccine contains, the vaccination isn’t so strong to make them sick, but it has enough for one’s immune system to develop resistance against the particular pathogen. As a result, the person gets future immunity against the disease without getting ill; if when exposed to the pathogen.

Today, with increasing community awareness regarding the benefits of vaccines against vaccine preventable diseases, increasing government role in strengthening immunization programs and increasing funding from several governments and non-governments sectors certainly help boost Global Vaccines Market in the near future. 

Key Topics Covered : 

1.    Research Findings

2.    Global – Vaccines Market and Forecast
2.1    Adult Vaccines Market
2.2    Pediatric (Infant) Vaccines Market

3.    Global – Adult Vaccine vs. Pediatric Vaccine Market Share

4.    Global – Vaccines Market Share and Forecast
4.1    Adult Vaccines Market Share
4.2    Pediatric (Infant) Vaccines Market Share

5.    Global – Vaccinated People
5.1    Adult Immunized and Forecast
5.2    Vaccinated Infant (Pediatric)

6.    Global – Vaccinated People Share
6.1    Vaccinated Adult Share
6.2    Vaccinated Infant (Pediatric) Share

7.    Global – Doses of Vaccines Administered and Forecast
7.1    Doses of Adult Vaccines Administered
7.2    Doses of Infant (Pediatric) Vaccines Administered

8.    Global – Doses of Vaccines Administered Share
8.1    Doses of Vaccines Administered to Adult Share
8.2    Doses of Vaccines Administered to Infant (Pediatric) Share

9.    Global – Vaccine Companies Market Share and Forecast

10.    Disease wise – Vaccines Market and Forecast
10.1    Influenza – Total Vaccines Market
10.2    Cervical Cancer (HPV) – Vaccines Market
10.3    Zoster (Shingles) – Vaccines Market
10.4    MMR (Measles, Mumps, and Rubella Vaccine) – Total Vaccines Market
10.5    Pneumococcal – Total Vaccines Market
10.6    Meningococcal – Total Vaccines Market
10.7    Hepatitis – Total Vaccines Market
10.8    TdaP and DTaP – Total Vaccines Market
10.9    Travel and Miscellaneous – Vaccines Market
10.10    Haemophilus Influenzae Type B (HIB) – Vaccines Market
10.11    Combos (Combination) – Vaccines Market
10.12    Polio – Vaccines Market
10.13    Rotavirus – Vaccines Market
10.14    Varicella – Vaccines Market

11.    Disease wise – Numbers of Vaccinated People & Forecast
11.1    Influenza – Total Number of Vaccinated People
11.2    Cervical Cancer (HPV) – Number of Vaccinated People
11.3    Zoster (Shingles) – Number of Vaccinated People
11.4    MMR – Total Number of Vaccinated People
11.5    Pneumococcal – Total Number of Vaccinated People
11.6    Meningococcal – Total Number of Vaccinated People
11.7    Hepatitis – Total Number of Vaccinated People
11.8    TdaP and DTaP – Total Number of Vaccinated People
11.9    Hib (Haemophilus Influenzae Type B) – Number of Vaaccinated Infants
11.10    Combos (Combination Vaccines) – Number of Vaccinated Infants
11.11    Polio – Number of Infants Immunized and Forecast
11.12    Rotavirus – Number of Vaccinated Infants
11.13    Varicella – Total Number of Vaccinated People

12.    Disease wise – Doses of Vaccines Administered and Forecast
12.1    Influenza – Doses of Vaccines Administered
12.2    Cervical Cancer (HPV) – Doses of Vaccines Administered
12.3    Zoster (Shingles) – Doses of Vaccines Administered
12.4    MMR – Doses of Vaccines Administered
12.5    Pneumococcal – Doses of Vaccines Administered
12.6    Meningococcal – Doses of Vaccines Administered
12.7    Hepatitis – Doses of Vaccines Administered
12.8    TdaP and DTaP – Doses of Vaccines Administered
12.9    Hib (Haemophilus Influenzae Type B) – Doses of Infant Vaccines Administered and Forecast
12.10    Polio – Doses of Infant Vaccines Administered
12.11    Rotavirus – Doses of Infant Vaccines Administered and Forecast
12.12    Varicella – Doses of Vaccines Administered

13.    Disease wise - Immunization Profile
13.1    Immunization Coverage (%) in Infants
13.2    Global Immunization Profile
13.3    Regional Immunization Profile

14.    Vaccines Key Players Sales and Forecast
14.1    GlaxoSmithKline, plc.’s Vaccines Sales
14.2    Merck & Co. Vaccines Sales
14.3    Sanofi Pasteur’s Vaccines Sales
14.4    Pfizer, Inc.’s Vaccines Sales
14.5    Global – Other Companies Vaccines Sales

15.    Vaccines – Products and Pipeline
15.1    GSK Vaccine Product Pipeline
15.2    Merck Vaccine Product Pipeline
15.3    Sanofi Vaccine Product Pipeline
15.4    Pfizer Vaccine Product Pipeline

16.    Top Mergers and Acquisitions in the Vaccine Industry

17.    Vaccines and Regulator’s Interventions
17.1    Making and Meeting Standards of Quality and Safety
17.2    Vaccine Funding

18.    Vaccine Market Drivers
18.1    Inclusion in National Immunization Schedule
18.2    Growing Immunization Coverage for HPV Vaccines
18.3    Increase in Prevalence of Infectious Diseases
18.4    Global Immunization Vision and Strategy (GIVS)
18.5    GAVI Model Fuelling Vaccine Manufacturers
18.6    Increasing Vaccine Availability in United States
18.7    The Vaccine Safety Data link Project
18.8    The Vaccine Injury Compensation Program
18.9    Transforming of Vaccine Technologies
18.10    Global Vaccine Action Plan by WHO (2011 - 2020)
18.11    Continuous Focus on Effective Communication Strategies

19.    Vaccines Market Challenges
19.1    Hurdles to Optimal use of Licensed Vaccines
19.2    Complexity of Vaccine Development & Approval System Thwarts Product Development
19.3    Shortening the Timeline for Vaccine Development
19.4    Refusal/Resistance to Vaccination
19.4.1    Vaccine Adverse Event Reporting System
19.5    Vaccine Shortages and Delays
19.6    Obstacles in Vaccine Research & Development
19.7    Barriers to New Entrants in the Vaccines Market

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research

Phone: +1-678-302-0700

Email: info@renub.com

Website: https://www.renub.com     

Follow us on LinkedIn: https://www.linkedin.com/company/renub-research